INTRODUCTION {#S1}
============

Neurodegenerative diseases (NDs) are a huge public health problem, and dissecting their pathophysiological mechanism is one of our greatest challenges. Neuroinflammation is an important component of many NDs, including Alzheimer disease (AD), frontotemporal dementia (FTD), Parkinson disease (PD), and others ([@R11]; [@R13]; [@R15]; [@R40]; [@R56]). However, the role of immune dysfunction in NDs remains paradoxical; there is evidence that the activation of microglia may induce neurotoxicity, but also evidence that it is protective, through the clearance of toxic protein aggregates ([@R6]). Thus, it remains controversial whether neurodegeneration is the consequence of hyperactivation or inactivation of the immune response, and what the triggers are that induce its dysfunction.

The immune response in the nervous system is not only triggered by pathogens but also by its linkage to autophagy ([@R40]). Autophagy is essential for removing damaged proteins and organelles, safeguarding cellular energy balance, and maintaining cellular homeostasis ([@R52]). Autophagy is also an alternative route of cell death that is distinct from apoptosis, and it is implicated in a wide variety of NDs ([@R5]; [@R34]). Fundamental questions remain, however: is autophagy a pro-death program or a protective program that enhances survival, and does disruption of autophagy serve as an early, triggering event in ND, or is it a late-acting piece of the mechanism?

The greatest risk factor for most NDs is aging ([@R55]). Aging broadly changes the physiology of the organism, in part by disrupting cellular homeostasis. The nervous system is particularly sensitive to the function and regulation of homeostatic mechanisms, including both autophagy and immunity, among many others ([@R34]; [@R44]). One issue confounding our understanding of human ND is that the normal modulation of immunity and autophagy by aging has obscured whether changes in these processes reflect a direct role in pathogenesis or simply a correlation among the processes of normal aging.

The mechanisms of autophagy and innate immunity, as well as aging, are significantly conserved between mammals and *Drosophila* ([@R17]; [@R28]). *Drosophila* has a well-regulated innate immune system that uses anti-microbial peptides (AMPs) as effector molecules, including several with clear mammalian orthologs. Two parallel pathways exist for the activation of AMP synthesis, under control of the receptors Toll and Imd (immune deficiency), and these are homologous to innate immune pathways in mammals ([@R22]). Toll and Imd, respectively, signal through the nuclear factor κB (NF-κB) transcription factors Dif and Relish, which promote the transcription of multiple classes of AMPs in *Drosophila*, including attacin, cecropin, diptericin, drosocin, drosomycin, defensin, and metchnikowin, as well as other immune effectors. Some recent studies in *Drosophila* have suggested a negative role for hyperactive innate immune response in neurodegeneration and aging ([@R3]; [@R20]; [@R37]), although other reports suggest a positive role for the overexpression of AMPs on aging ([@R24]). Therefore, in flies as in mammals, the relation among these processes in the progression to disease remains unclear.

We have shown previously that increased or decreased activity of cyclin-dependent kinase 5 (Cdk5), achieved by altered expression of its essential activating subunit, Cdk5α (also called D-p35), causes a neurodegenerative syndrome in *Drosophila* that has extensive similarities to human NDs, including adult-onset degeneration and the death of neurons that are associated with learning and memory (mushroom body \[MB\] neurons), impaired auto-phagy, sensitivity to oxidative stress, and progressive loss of motor function, along with an accelerated rate of aging ([@R46]; [@R49]). Cdk5 is a divergent member of the cyclin-dependent kinase family that does not associate with a classical cyclin for its activation and is not required for cell-cycle progression. Cdk5 is expressed ubiquitously; however, its function is limited to postmitotic neurons due to the restricted expression of its activating subunit ([@R7]; [@R50]). Cdk5 activation in mammals requires specific binding with either p35 or the related protein p39 ([@R19]), while in *Drosophila* there is only a single p35 ortholog ([@R8]). Deregulated Cdk5 has been associated with different NDs in humans. For example, in the case of AD, Cdk5 causes hyperphosphorylation of tau and is involved in the formation of neurofibrillary tangles ([@R9]). In the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model of PD, Cdk5 causes phosphorylation of an antioxidant enzyme, Prx2, which is associated with cell death ([@R38]). Notably, both gain and loss of function of Cdk5 induce neuronal death and neurodegeneration in cell culture and in mouse models, perhaps because of cross-regulatory interactions among a network of kinases with closely related target-site specificity ([@R9]; [@R36]; [@R47]).

Here, we unravel the relations among the core phenotypes of Cdk5-associated neurodegeneration in *Drosophila*. We show that increasing or decreasing the expression of *Cdk5α* impairs autophagy and that this in turn causes the degeneration of a sensitive neuronal population through hyperactivation of the innate immune response. We first show that the activation of innate immunity occurs independently of aging in *Cdk5α*-altered *Drosophila*. We then demonstrate that dopamine (DA) neurons, like MB neurons, undergo age-dependent degeneration when we increase or decrease the expression of *Cdk5α*. Furthermore, we show that the activation of innate immunity by altered *Cdk5α* is both necessary and sufficient to cause DA neuron death, and that the disruption of autophagy by altered *Cdk5α* is necessary and sufficient to account for the hyperactivation of immunity. Our data provide a clear picture of the relation among three of the key features of NDs, aging, autophagy, and immunity, revealing that autophagy and immunity make up a dependent genetic pathway that assaults neurons, in conjunction with the overall fragility induced by aging.

RESULTS {#S2}
=======

Increased or Decreased Expression of *Cdk5α* Causes Age-Dependent Degeneration of Dopaminergic Neurons in *Drosophila* {#S3}
----------------------------------------------------------------------------------------------------------------------

MB cell counting and global gene expression profiling in *Drosophila* that are null mutant for *Cdk5α* (*Cdk5α null*) or have mild (2.5- to 3-fold) overexpression of *Cdk5α* (*Cdk5-OE*; from the introduction of four extra copies of the wild-type *Cdk5α* genomic locus) revealed age-dependent degeneration of MB neurons ([@R46]). While comparing the gene expression profile obtained upon altering *Cdk5α* to that from other *Drosophila* models of degeneration, we noted a striking similarity with the profile of flies bearing a mutation in the fly ortholog of the human PD-associated gene *Pink1* (Pearson *r* \> 0.36; corrected p \< 0.05 in three out of four conditions examined; Table S1). *Pink1* mutant flies, like humans, lose DA neurons as they age ([@R35]). Moreover, flies with altered *Cdk5α* show impaired motor function with age, reminiscent of *Pink1* mutant flies. We therefore counted DA neurons using whole-mount immunostaining with anti-*Drosophila* tyrosine hydroxylase (DTH). We found that the number of neurons was not significantly changed in wild-type flies until 45 days of age, whereas both *Cdk5α null* and *Cdk5α-OE* show an earlier, age-dependent loss of DA neurons (Figures [1A, 1B](#F1){ref-type="fig"}, and [S1](#SD1){ref-type="supplementary-material"}; [Table S2](#SD2){ref-type="supplementary-material"}). Consistent results were observed using a different anti-TH antibody ([Figure S2B](#SD1){ref-type="supplementary-material"}) or by co-labeling with TH-GAL4; UAS-nls-mCherry and counting double-tagged neurons at 30 days old ([Figure S2A](#SD1){ref-type="supplementary-material"}). We verified the specificity of the mutant phenotype by restoring the DA number with a single copy of a *Cdk5α* genomic trans-gene in *Cdk5α null* flies ("rescue" hereafter: *w*^+^*; Cdk5α/Cdk5α; P\[w*^+^*,Tn Cdk5α\]*^*R157/*+^) ([Figure 1C](#F1){ref-type="fig"}; [Table S2](#SD2){ref-type="supplementary-material"}). Note that we typically assay degeneration at 30 days, since by 45 days, only the last few percent of mutant flies survive and these are not representative of the starting population ([@R46]). These data show that the altered expression of *Cdk5α* causes age-associated degeneration of DA neurons.

Altering the Expression of *Cdk5α* Hyperactivates the Expression of AMP Genes {#S4}
-----------------------------------------------------------------------------

Using global gene expression profiling, we previously developed a comprehensive, quantitative, and unbiased metric for the physiological age of wild-type flies, and applying it to young, 10-day-old *Cdk5α null* and *Cdk5α-OE* flies, we demonstrated that acceleration of the intrinsic rate of aging was a major contributor to *Cdk5α*-associated neurodegeneration ([@R46]). These data, however, suggested that there were also non-aging components of degeneration acting in concert. To identify those components, we applied principal-component analysis (PCA) to our expression profiling data. PCA cleanly apportions the effects of aging to PC1 and PC2, but reveals the presence of a third component, PC3, that contributes little variance to wild-type but separates the *Cdk5α*-altered genotypes roughly in proportion to the severity of the degeneration phenotypes that they will later display ([Figure 2A](#F2){ref-type="fig"}). Identification of the genes that contribute to PC3 reveals that nearly half are components of the innate immune system, including members of several families of antimicrobial peptide (AMP) genes ([Figure 2B](#F2){ref-type="fig"}).

We validated and extended these expression profiling data by qRT-PCR of RNA isolated from fly heads in *Cdk5α null*, *Cdk5α-OE*, and control *Drosophila* at various ages. We found that *Cdk5α*-altered flies have a significant upregulation of AMPs at older ages (30 and 45 days; [Figure 2C](#F2){ref-type="fig"}; [Table S2](#SD2){ref-type="supplementary-material"}) compared to controls. For example, the expression of individual AMPs in 45-day-old controls varies from 0.72 ± 0.08 to 7.37 ± 0.79 as compared to 3-day-old controls, while in *Cdk5α null*, expression ranges from 4.26 ± 0.20 to 173.76 ± 10.53 and 8.75 ±± 0.55 to 105.38 ± 6.49 for *Cdk5α-OE*. Expression of AMPs in 30-day-old *Cdk5α null* was partially rescued by restoring a single copy of the *Cdk5α* genomic transgene ([Figure 2D](#F2){ref-type="fig"}; [Table S2](#SD2){ref-type="supplementary-material"}), demonstrating the specificity of the AMP-upregulation phenotype. Thus, the expression of AMP genes is enhanced in flies with an altered expression of *Cdk5α* as early as 10 days after eclosion, increasing to much greater levels as the flies age. Because the increase in AMP expression is even greater than the intrinsic activation of AMPs with aging, we refer to it as hyperactivation of AMP expression. A crucial question is which cells are making the AMPs in *Cdk5α null*. We assayed the tissue distribution of a *Drosomycin-GFP* gene trap and observed widespread expression in neurons, and some in glia, in addition to the expected expression in cells resembling circulating immune cells ([Figure 3A](#F3){ref-type="fig"}).

Activation of Immunity Is Necessary and Sufficient to Promote DA Neuron Loss in the Brains of Flies with Altered Cdk5α Expression {#S5}
---------------------------------------------------------------------------------------------------------------------------------

Since overexpression of AMPs correlated with the severity of degeneration, and previous studies have reported generalized neurotoxicity upon the overexpression of AMPs in *Drosophila*, we hypothesized that the elevated AMPs in aged *Cdk5α null* and *Ckd5α-OE* flies are toxic to DA neurons. We first over-expressed various AMPs individually (attacin, drosocin, drosomycin, and metchnikowin; [Figure S3](#SD1){ref-type="supplementary-material"}) in DA neurons using *TH-Gal4* and observed a significant loss of DA neurons even with individually overexpressed AMPs ([Figure 4A](#F4){ref-type="fig"}; [Table S2](#SD2){ref-type="supplementary-material"}). We note that the magnitude of degeneration was not as high upon the overexpression of any single AMP as in *Cdk5α null* and *Cdk5α-OE* flies, which have a simultaneous overexpression of multiple AMPs. Note also that the *UAS-Drosocin* and *UAS-Metchnikowin* transgenes have significant GAL4-independent expression as assayed by qRT-PCR; consistent with this, these lines have reduced DA cell numbers even without GAL4. Nevertheless, these results demonstrate that an increase in AMP expression in wild-type *Drosophila* is sufficient to cause the loss of DA neurons.

Next, we sought to test whether blocking immune activation, including AMP induction, would protect DA neurons from degeneration in *Cdk5α null*. We generated *Cdk5α* mutant flies that were heterozygous for a null allele of Relish, an NF-κB transcription factor that is a central activator of humoral innate immunity ([@R12]). We found that *Cdk5α null;Rel*^*E20*^*/TM6B*s have significantly lower expressions of all of the AMPs examined (22%--90% rescue, depending on AMP) ([Figure 4B](#F4){ref-type="fig"}; [Table S2](#SD2){ref-type="supplementary-material"}), along with significantly higher numbers of surviving DA neurons, as compared to 30-day-old *Cdk5α null* flies ([Figure 4C](#F4){ref-type="fig"}; [Table S2](#SD2){ref-type="supplementary-material"}). The same result was obtained when the experiment was repeated without the balancer chromosome present ([Figure S4](#SD1){ref-type="supplementary-material"}). These results strongly suggest that hyperactivity of the innate immune response, including over-expression of AMPs, is necessary and sufficient to induce the degeneration of DA neurons in animals with reduced *Cdk5α* expression. We extended this experiment by performing RNAi knock down of Rel selectively in neurons of *Cdk5α null*, using an *ELAV-GAL4* driver, and found significantly reduced AMP expression and rescue of DA neuron loss ([Figures 3B and 3C](#F3){ref-type="fig"}). These data confirm the rescue of DA neurons by reduced levels of Rel and also show that immune activation is specifically required in neurons to produce lethality, which is consistent with the AMP expression pattern observed above.

Finally, we tested whether immune activation and consequent DA neuron loss may occur because of increased bacterial infection in mutant flies. First, we measured bacterial load by PCR of 16S rDNA among controls, *Cdk5α null*, and *Cdk5α-OE* and found no significant difference (data not shown). Second, we prepared axenic flies and found that the activation of AMP expression and DA neuron loss occur in 30-day-old Cdk5α-altered flies raised under sterile conditions just as they do under normal conditions ([Figure S5](#SD1){ref-type="supplementary-material"}). This argues for the idea that the activation of immunity is not due to exacerbated bacterial infection in Cdk5α-altered conditions.

Altered Expression of *Cdk5α* Disrupts Autophagy in *Drosophila* {#S6}
----------------------------------------------------------------

If altering *Cdk5α* does not intensify microbial challenge, why does it activate the innate immune response? Defective autophagy can stimulate innate immunity, including AMP expression ([@R51]; [@R54]), and data from us and others show that altering *Cdk5α* levels or inactivating Cdk5 kinase activity can disrupt autophagy ([@R30]; [@R46]; [@R49]). Thus, we hypothesized that reduced autophagy in flies having an altered level of *Cdk5α* may be responsible for overactivated innate immunity. This conjecture was supported by our PCA of microarray data, as four out of the nine genes that were downregulated by altered *Cdk5α* expression were proteases, protease regulators, and a lipid hydrolase (CG12256, SPH93, CG3513, and Cyp4g1; [Figure 2B](#F2){ref-type="fig"}).

Previous experiments demonstrated that *Cdk5α*-altered flies have distorted autophagy in the brain at an older age ([@R46]; [@R49]). To quantify autophagic flux specifically in DA neurons, we assayed the p62 ortholog, Ref(2)P (refractory to sigma P), and a tandem tagged Atg8 (*GFP-mCherry-Atg8a*). Ref(2)P accumulates if autophagy is disrupted ([@R29]). The tandem tagged Atg8a assays autophagic flux per se; since its GFP fluorescence is quenched in acidified autolysosomes, functional lysosomes bearing the reporter contain red puncta, while autophagosomes that fail to acidify accumulate double-tagged (yellow) puncta ([@R18]). Counting Ref(2)P puncta in the brains of 30-day old flies revealed that *Cdk5α*-altered flies have a significantly higher number of puncta than controls ([Figures 5A and 5B](#F5){ref-type="fig"}). Three-dimensional (3D) reconstruction clearly revealed the accumulation of Ref(2)P inside TH^+^ DA neurons specifically, as well as in the brain overall ([Figure 5A](#F5){ref-type="fig"}). To assay autophagy flux in *Cdk5α null* flies, we expressed tandem tagged Atg8a (*UAS-GFP-mCherry-Atg8a*) using *TH-Gal4*. At 30 days of age, the PPL1 cluster of DA neurons shows mostly double-positive autophagosomes (positive for both GFP-Atg8a and mCherry-Atg8a), while the age-matched control has mostly single-positive (mCherry only) autolysosomes ([Figure 5C](#F5){ref-type="fig"}), demonstrating impaired autophagic flux in the mutant.

Since the experiments above revealed autophagosomes failing to convert to acidified autolysosomes in *Cdk5α null*, we hypothesized that there may be a defect in lysosome metabolism. We examined *Vha-13-GFP*, a reporter for the vacuolar (H^+^)-ATPase that has a prominent role in lysosome acidification ([@R57]). Extract of the heads of 30-day-old *Cdk5α null;Vha-13-GFP* flies was analyzed by immunoblotting using anti-GFP antibody, and revealed that *Cdk5α null* have significantly lower amounts of Vha protein than controls ([Figure 5D](#F5){ref-type="fig"}). This observation was extended by qRT-PCR assay showing reduced transcript of Mitf, a master regulator of the lysosomal-autophagy pathway, including v-ATPase expression ([@R2]; [@R57]), in 30-day-old mutants as compared to controls ([Figure 5E](#F5){ref-type="fig"}). Along with the reduction in Vha, both *Cdk5α null* and *Cdk5α-OE* flies also had a significantly lower level of cysteine proteinase-1 (Cp1, also known as cathepsin L; [Figure 5F](#F5){ref-type="fig"}), another marker for lysosomal metabolism. These data demonstrate that the *Cdk5α* mutation reduces autophagic flux generally, including in DA neurons, which is consistent with the reduced expression of proteins required for lysosomal metabolism in the *Cdk5α* mutant and of the transcription factor that promotes their expression.

Disruption of Autophagy Is Responsible for the Activation of Immunity and Consequent Loss of DA Neurons upon Altering the Level of Cdk5α {#S7}
----------------------------------------------------------------------------------------------------------------------------------------

Given the disruption of autophagy by altered Cdk5α and the potential linkage of autophagy to immunity, we tested whether impairment of autophagy can cause overexpression of AMPs and progressive loss of DA neurons. We first quantified AMP expression and DA neuron number in an *Atg8a* mutant (*Atg8a*^*1*^*/Y*). *Atg8a* is one of the two *ATG8* paralogs in *Drosophila* ([@R29]). Atg8a acts in autophagosome formation, and while the *Atg8a* mutant is viable, it has poor autophagy efficiency ([Figure 6A](#F6){ref-type="fig"}). We found that *Atg8a*^*1*^*/Y* flies have a significantly elevated expression of AMPs as compared to age-matched controls (5.46 ± 0.0.65- to 16.57 ± 1.18-fold depending upon the AMP; [Figure 6B](#F6){ref-type="fig"}; [Table S2](#SD2){ref-type="supplementary-material"}). Moreover, while *Atg8a* mutant animals have the same number of DA neurons as controls at 3 days of age, they have significantly fewer DA neurons at 30 days of age ([Figure 6C](#F6){ref-type="fig"}). These data demonstrate that the disruption of autophagy is sufficient to cause the overexpression of AMPs and the age-dependent loss of DA neurons.

Finally, we investigated whether restoring lysosomal gene expression and metabolism rescues autophagy, and if so, whether this would restore AMP gene expression and DA neuron survival. Since strong overexpression of Mitf is extremely toxic ([@R57]), we took advantage of a third chromosome insert of *ELAV-Gal4* (a pan-neuronal driver) with extremely low adult activity to restore the Mitf level in *Cdk5α* null flies (1.68 ± 0.10 fold versus *Cdk5α* null and 0.86 ± 0.05 fold versus controls; [Figure 5E](#F5){ref-type="fig"}). We then counted Ref(2)P puncta in 30-day-old flies, which revealed a significant improvement in autophagy in flies with Mitf restoration (*Cdk5α null; elav-GAL4 \> UAS-Mitf*) ([Figure 6D](#F6){ref-type="fig"}). We next found significantly reduced expression of AMPs in *Cdk5α* null flies with restored Mitf expression as compared to age-matched *Cdk5α* null ([Figure 6E](#F6){ref-type="fig"}; [Table S2](#SD2){ref-type="supplementary-material"}). Finally, we counted DA neurons and discovered significant restoration of DA neuron viability ([Figure 6F](#F6){ref-type="fig"}). Thus, restoring autophagy by the mild expression of Mitf in *Cdk5α null* flies reduces AMP expression and rescues DA neuron loss. These data demonstrate that reduced auto-phagy efficacy in the *Cdk5α* mutant is necessary and sufficient to induce high-level AMP expression and is associated with DA neuron loss.

DISCUSSION {#S8}
==========

Here, we show that altering the level of the Cdk5 activating subunit, Cdk5*α*, impairs autophagy, which leads to the upregulation of the innate immune response, including antimicrobial peptides (AMPs), and this in turn causes age-dependent degeneration of dopamine neurons in *Drosophila*. PCA of transcriptome data revealed that the overexpression of AMPs drives much of the aging-independent component of the gene expression changes between flies with altered levels of *Cdk5α* and wild-type flies, even before the onset of overt degeneration. Directed overexpression of AMPs is sufficient to cause the death of DA neurons in otherwise wild-type flies, while blocking immune activation in *Cdk5α* mutants by reducing the expression of the NF-κB transcription factor, Rel, rescues DA neuron survival. The activation of immunity in turn is caused by *Cdk5α*-associated disruption of autophagy, as hindering autophagy with a mutation in *Atg8a* is sufficient to enhance AMP expression and kill DA neurons, while rescuing autophagy in a *Cdk5α* mutant by overexpression of the TFEB transcription factor, Mitf, restores the AMP level and rescues DA neurons. These data reveal a simple, linear, dependent genetic pathway, encompassing both autophagy and innate immunity, which, while rigorously separable from aging, interacts with the effects of aging to lead to the degeneration of DA neurons *in vivo*.

Two major variables have confounded our understanding of the relation of autophagy and immunity to degeneration. The first is age: neurodegeneration occurs with aging, and both auto-phagy and the immune response change with age, so how does one discriminate the effects of disease from the normal, variable course of aging? The second is that both autophagy and the immune response are homeostatic processes: how does one determine whether alterations in autophagy or immunity are part of the disease mechanism, or are part of the organism's response to pathology? This second problem is particularly difficult because both autophagy and immunity are normally maintained within narrow limits. Therefore, robust experimental manipulation of these processes will certainly cause pathology, but not necessarily pathology that is relevant to the mechanism of NDs.

The data reported here allow us to answer these questions. First, statistical analysis of transcriptome profiling revealed that changes in innate immunity drive much of the non-aging component of gene expression differences between wild-type flies and flies destined to undergo degeneration. Thus, PCA reveals the existence of a large component of immune hyperactivation over and above that due to the natural progression of aging, and qRT-PCR quantification confirms that it correlates with the severity of degeneration. Second, multiple lines of evidence demonstrate that defective autophagy and hyperactive immunity are causal for DA neuron degeneration and furthermore, that they constitute a pathway, with defective autophagy being responsible for immune activation, and immune activation inducing neuron loss. Below, we consider each step of the degeneration pathway.

Altering the Level of Cdk5α Expression Causes Reduced Efficiency of Autophagy {#S9}
-----------------------------------------------------------------------------

Our data, together with published work, suggests that there are two parts to the association of autophagy with Cdk5/Cdk5α activity: the efficiency of autophagy changes with age, which is modulated by Cdk5, and there are mechanisms by which Cdk5 regulates autophagy more directly ([@R29]; [@R46]). The autophagy-lysosomal system ensures continuous autophagic flux that promotes a healthy cellular environment ([@R2]), and it requires the acidic lysosomal environment that is maintained by the vacuolar-type H^+^-ATPase (V-ATPase) complex ([@R25]). We find that V-ATPase (Vha-13), as well as the Cp1 level, are reduced in the heads of *Cdk5α null* flies, and overexpression of a master regulator of lysosomal function, the TFEB Mitf, restores autophagy to these flies, supporting the hypothesis that the compromised autophagy in *Cdk5α null* flies is associated with abnormal lysosomal metabolism. It is not clear what molecular events are responsible for the reduction of Mitf transcript and reduced expression of V-ATPase upon altering the Cdk5α level, but expression profiling of wild-type *Drosophila* shows that most of the V-ATPase family genes are downregulated with age ([@R46]) and that *Cdk5α*-altered *Drosophila* have an accelerated aging rate ([@R46]). Thus, we hypothesize that the enhanced rate of aging from altered Cdk5α contributes to the reduced expression of the V-ATPase family, leading to lysosomal abnormality and compromised autophagy, probably in combination with more direct effects of Cdk5 on components of the autophagy machinery, such as the RNA-splicing factor acinus ([@R30]).

Disruption of Autophagy Causes Hyperactivation of Innate Immunity {#S10}
-----------------------------------------------------------------

The reduced autophagy in animals with an altered level of *Cdk5α* was accompanied by an age-dependent increase in the expression of AMPs. While autophagy is regarded principally as a homeostatic process that removes harmful substances and maintains cellular metabolism by recycling substrates, it is not limited to these functions ([@R53]; [@R52]). Autophagy influences multiple aspects of immune system function and regulation in both vertebrates and invertebrates, although the mechanisms are not yet fully understood ([@R23]; [@R41]; [@R54]). One recent theory is that the disruption of various aspects of physiological homeostasis is monitored by the organism as *prima facie* evidence of microbial attack and used as a signal for the activation of immunity and detoxification pathways ([@R26]). Mechanistically, there are at least two possible modes by which autophagy could influence inflammation--directly, by modifying the activity of the inflammasome complex ([@R21]), and indirectly, by autophagic clearance of molecules that activate an inflammatory response ([@R23]; [@R39]).

We show here that the increase in AMP expression upon altering Cdk5α expression is a consequence of reduced autophagy. Reducing autophagy by the mutation of *Atg8a* was sufficient to induce the overexpression of AMPs. Moreover, rescuing autophagy using Mitf expression selectively in the neurons of *Cdk5α null* animals restored the expression of AMPs. These results strongly suggest that reduced autophagy efficiency is causal for the overactivation of innate immunity in *Cdk5α null* flies, reinforcing the idea that autophagy has a significant role in regulating immunity and inflammatory response. We exclude in two ways the model that increased immunity in Cdk5α-altered flies is a result of increased propensity for infection. First, bacterial load is not altered in flies with increased or decreased Cdk5α, and second, both activation of AMP expression and loss of DA neurons occurs in flies with altered Cdk5α when they are raised in germ-free conditions, just as it does under standard growth conditions.

Hyperactivation of Innate Immunity Induces Age-Dependent Loss of DA Neurons {#S11}
---------------------------------------------------------------------------

Three lines of evidence argue that the age-dependent loss of DA neurons in *Drosophila* with altered levels of *Cdk5α* is due to the hyperactivity of innate immunity, including the overexpression of AMPs. First, the age-dependent overexpression of AMPs in the heads of Cdk5*α null* and Cdk5*α-OE* flies is accompanied by the age-dependent loss of DA neurons, while blocking immune activation by reducing the *Relish* level in *Cdk5α null* flies restores DA neurons. Second, the overexpression of AMPs is sufficient to cause the age-associated loss of DA neurons in flies, even in the absence of an exogenous stressor. Neurotoxicity of AMPs has been shown previously in other neuronal subsets ([@R3]; [@R20]; [@R37]). Third, we also observed the overexpression of AMPs and age-dependent DA neuron loss in a different genetic paradigm, disruption of autophagy in a hemizygous *Atg8a* mutant. Therefore, we argue that overactive innate immune response is responsible for the degeneration of DA neurons in an age-dependent manner in *Drosophila* with altered Cdk5*α*. Our data regarding the neurotoxicity of AMPs, and the neuroprotective role of reduced *Relish*, are reminiscent of observations made in other experimental paradigms, and potentially explains the data obtained in previous studies of immunity and neurodegeneration ([@R3]; [@R20]; [@R37]). In future experiments, it will be interesting to examine the potential roles of the other NF-κB paralogs *dif* and *dorsal*.

In our PCA, eight of the nine circulating immune effectors that were hyperactivated by altered Cdk5α were AMPs. Taken together with the data above, this suggests that AMP overexpression likely plays a central role in the Cdk5α-associated loss of DA neurons. We note, however, that Rel induces many aspects of immunity aside from AMPs ([@R27]). Moreover, we cannot rule out the possibility that the cell lethality of overexpressed AMPs could occur via a mechanism that is different from that of immune-correlated cell death in altered Cdk5α conditions ([@R42]). Therefore, it remains possible that other aspects of the immune response contribute to DA neuron loss in this model, in addition to or instead of AMP activation.

Two lines of experiments show that AMP expression is activated in neurons in the *Cdk5α null*: examination of an AMP reporter line and rescue by neuron-specific suppression of the immune response. The nature of AMP toxicity has been controversial, but our finding of enhanced AMP expression in neurons may be relevant. For example, it could be that the activation of endoplasmic reticulum (ER) stress--or the failure to activate protective mechanisms such as the ER stress response--may contribute to the toxicity of expressing secreted immune proteins such as AMPs in cells that do not normally produce them at high levels ([@R42]). These data also raise the question of whether activation of immune genes in non-immune cells, particularly neurons, may be part of the pathogenic mechanism in human NDs.

The overexpression of AMPs in DA neurons does not induce degeneration in 3-day-old flies; however, at 30 days old, it results in a significant loss of DA neurons. This is true of direct GAL4-driven overexpression of AMPs, overexpression due to an autophagy mutant, and overexpression due to the altered expression of *Cdk5α*. Conversely, aging to 30 days alone, in the absence of immune activation, is not sufficient to produce DA neuron loss. We therefore suggest that DA loss reflects a synergistic interaction between the direct, toxic effects of AMP overexpression and the general cellular fragility produced by aging ([@R14]; [@R46]).

All of the genes we have manipulated and all of the interactions we have examined are conserved in mammals, and each individually has been implicated in human NDs. For example, the accumulation of autophagic vacuoles (AVs) has been observed in the brains of patients with PD ([@R1]), and data from model organisms suggest the association of familial PD genes with autophagy ([@R31]; [@R48]), although it remains unclear whether disease is associated with autophagy that is excessive, insufficient, or directed against inappropriate targets. Similarly, in recent years, inflammation has gained recognition as a factor promoting degeneration ([@R16]; [@R43]), although it has been controversial whether it is a cause or a consequence of cell loss and whether immune activation or insufficiency is to blame for ND. Moreover, epigenomic features in a mouse p25/Cdk5 model of degeneration and in human AD also highlight immunity as a predisposing process in degeneration ([@R11]). Finally, just as our data indicate that degeneration arises from the synergistic interaction of inflammation and aging, [@R4] have reported evidence for the age dependence of nigrostriatal degeneration upon the CNS-directed expression of the innate immune mediator interferon-γ in mice. However, while previous studies of degeneration have identified some of the same processes we describe here, those studies have not been able to establish whether disease arises from hyperactivity, inactivity, or the mistaken activity of common homeostatic mechanisms. Moreover, it has not been possible to connect those processes to mechanistic pathways, or to discriminate the progression of disease from the progression of normal aging. By contrast, using the precise genetic tools of the fly and our previous construction of a systems-level metric for physiological aging, we have shown here that a simple, dependent genetic pathway, comprising reduced autophagy and hyperactive immunity, interacts synergistically with disease-associated acceleration of the intrinsic rate of aging to produce the overall outcome of adult-onset neurodegeneration in the fly. Given the conservation of genes, pathways, and cellular phenotypes, it seems very likely that the processes we reveal here also play a central role in the development and progression of human ND.

STAR⋆METHODS {#S12}
============

CONTACT FOR REAGENT AND RESOURCE SHARING {#S13}
----------------------------------------

All requests for reagent and resources should be directed to the lead contact, Dr. Edward Giniger (<ginigere@ninds.nih.gov>).

EXPERIMENTAL MODEL AND SUBJECT DETAILS {#S14}
--------------------------------------

Flies were maintained on standard cornmeal-molasses *Drosophila* media at 25°C and 50% humidity with 12h light/dark cycle. Oregon Red (w^+^) was used as the wild-type control unless otherwise stated. Male flies were used in all experiments. *Cdk5α null*, *Cdk5α-OE* and *Cdk5α null; Tn\[Cdk5*^*+*^*\]* (ie., rescue) stocks have been described previously ([@R7]; [@R8]; [@R46]; [@R49]). During aging, flies were transferred to new vials every 48h. Complete genotypes for all stocks are listed by Figure in [Table S3](#SD1){ref-type="supplementary-material"}, and sources of fly stocks are provided in [Key Resources Table](#T1){ref-type="table"}.

METHOD DETAILS {#S15}
--------------

### Immunohistochemistry and Imaging {#S16}

Whole brains were dissected after fixation with 8% paraformaldehyde (PFA) in PBS for 10min. Brains were blocked with 5% heat inactivated Fetal Bovine Serum (FBS) in PBS+0.2% Triton X-100 (1XPBS-T) for 2hr at room temperature (RT) followed by two-night incubation at 4°C with primary antibodies at appropriate dilution. After antibody staining, brains were mounted on slides with VectaShield mounting medium. Microscopy was performed on a Zeiss NLO510 confocal microscope or with the Zeiss LSM880.

For counting dopaminergic neurons, control, *Cdk5α null*, and *Cdk5α-OE* male flies were collected at 3d-age and aged to 10-, 30-, or 45-days. Brains were incubated with Anti-DTH or Anti-TH antibody (1:200) at 4°C for two nights followed by washing and staining with appropriate secondary antibody (1:400). Images were acquired using a 20-X objective. Individual brain hemispheres were analyzed using ImageJ (National Institute of Health) cell counter plugin. Note that there is not perfect agreement in the number of presumptive DA neurons identified by anti-TH versus anti-DTH. However, the mean difference in cell number produced by each genetic manipulation reported here was similar using either antibody.

For Ref(2)P accumulation and counting, staining of 30d-old brain of male flies was performed using Anti-Ref(2)P (1:100) and Anti-TH (1:200) as primary antibodies and respective secondary antibodies (1:400) were used. Images were acquired using a 40-X objective. Post-acquisition, images were processed for deconvolution using AutoQuant X2. Maximum intensity projection (MIP) of Deconvoluted images were used for counting of Ref(2)P puncta using ImageJ. In brief, MIP of Ref(2)P stained brains were processed for thresholding followed by binarization and watershed. Analyze Particle tool was then used to count puncta in two different size ranges (0.02--0.40μm^2^ and \> 0.40μm^2^). Number of puncta was presented as mean ± SEM. The visualization of Ref(2)P puncta was done by Imaris software using 3D cropping and surface modeling using Ref(2)P- and TH- stained brain.

For examination of autophagy flux using *TH-GAL4*, *UAS-GFP-mCherry-atg8a* flies, unfixed brains of desired genotypes at 30d-age were dissected and mounted in Schneider′s *Drosophila* Medium. Images were acquired using Zeiss LSM880 confocal microscope using a 40-X objective, focusing on PPL1 clusters of DA neurons.

For examination of Drosomycin-GFP expression in *Cdk5α null* flies, brains of desired genotypes were fixed as above, dissected, and stained with Anti-GFP (1:200), Anti-ELAV (1:50) and Anti-Repo (1:50) antibodies and appropriate secondary antibodies (1:400). Stained brains were imaged using 40X objective. Images were processed for deconvolution using AutoQuant X3 and relevant planes of the Z stack were projected to provide representative images.

### Western immunoblotting {#S17}

Preparation of extract from flash frozen 30d-old flies and western blotting were performed as described previously ([@R46]). In brief, the heads of 20 male flies were separated from the rest of the body and homogenized in lysis buffer (2% SDS, 150mMNaCl, 50mM Tris, pH 7.5) containing protease inhibitors. Protein homogenate was centrifuged at 5000 rpm for 5min at 4°C. Protein supernatant was collected and transferred to fresh 1.5ml Eppendorf tube followed by mixing with BoldLDS sample buffer and Boldreducing agent (for 40μl total volume 10μl BoldLDS sample buffer and 4μl Boldreducing agent was used). Mixture was then incubated for 10min at 70°C followed by 2min incubation at 85°C. Proteins were resolved on a 4%--12% Bis-Tris plus gel and transferred onto iBlot2 NC membranes using the iBlot 2 system (Invitrogen/Thermo Fisher Scientific). After transfer, membranes were incubated in blocking solution (5% milk in 1XTBS-0.2% Triton X-100) for 2 hours at room temperature. Membranes were probed with primary antibodies overnight at 4°C. Primary antibodies included anti-GFP (1:1000), anti-Cp1 (1:500) and anti-β-Tubulin (*1:500*). Infrared fluorescent IRDye secondary antibodies, were applied for 20 minutes at room temperature (1:5000) followed by washing with 1XTBS-0.2% Triton X-100. Visualization and quantification was carried out using the LI-COR Odyssey scanner and software (LI-COR), with tubulin as a loading control.

### Principal Component analysis using microarray data {#S18}

PCA was performed on our previously-published microarray-based gene expression profiling dataset from the heads of flies with altered Cdk5*α*-expression, specifically on the set of age-classifier genes we identified ([@R46]). In that study, selection as an "age classifier gene" was restricted to those genes having a significant difference of expression between ages (ANOVA) under multiple comparison correction condition (BH FDR p \< 0.05) that also survived a leave-one-out (LOO) selection challenge in k-nearest neighbor (knn) analysis 100% of the time. For PCA, modeling of expression for these genes was accomplished using principal component regression followed by AIC-step optimization. Principal component loadings for the genes modeled were subset by component and a standard z-score calculated per gene. Genes having a standard z-score magnitude \> 2 were subset as those most contributing to the percent variance explained by each component.

### qRT-PCR of head RNA {#S19}

RNA was isolated from 25 *Drosophila* heads using TRI reagent and synthesis of cDNA performed with High Capacity cDNA Reverse Transcription Kit using 1000ng RNA, following the manufacturer's instructions. The expression of genes was quantified on a QuantStudio 6 Flex Real-Time PCR System using PowerUp SYBR Green Master Mix. Primer sequences are provided in [Table S5](#SD1){ref-type="supplementary-material"}. PCR was performed by the method of ([@R3]) with PCR conditions as follows: 35 cycles: step 1: 95°C for 10 s, step 2: 60°C for 30 s, step 3: 72°C for 40 s each cycle. The quantification of each gene, relative to rp49, was calculated using the DDCt method relative to 3d- or 30d-old control, as indicated.

### Comparison of Cdk5α expression profile to published datasets {#S20}

Raw expression files representing mutant conditions other than *Cdk5α-OE* and *Cdk5α null* in fly were downloaded from NCBI GEO: GSE23802, GSE9571, GSE20202, GSE10940, GSE26246, GSE25009 and EMBL-EBI ArrayExpress: E-MEXP-3645. Pre-processing of these files was performed by set, with noise modeling, noise filtering, and significance testing performed as described previously ([@R46]). Thus, noise-biased expression values were removed using lowess modeling to look for a relationship between mean gene expression and the corresponding coefficient of variation (CV). Lowess fits were then over-plotted to identify the common low-end expression value where the relationship between mean expression (signal) and CV (noise) deviated from linearity (mean expression value = 7.5). Expression values less than this value were set to equal 7.5, while gene probes not having at least one sample greater than 7.5 were discarded as non-informative. Fold changes observed for genes deemed to have differential expression between a mutation condition and its respective control were coded +1 or −1, depending on direction of change. These coded fold-changes were then intersected by gene symbol with similarly coded fold- changes observed for 10D Cdk5α-OE versus 10D Control and 10D Cdk5α null versus 10D Control. Spearman correlation was next applied to these intersections; providing for both a Rho estimate and an uncorrected p value per gene, and p values were then corrected via Benjamini-Hochberg procedure.

### Generation of Axenic culture of *Drosophila* {#S21}

Axenic culture of control, Cdk5α null and Cdk5α-OE flies were generated using eggs collected from sterile grape plates. Eggs from the grape plate were harvested using PBS followed by rinse with 70% ethanol. Washed eggs were dechorionated by bleaching using 3% Sodium hypochlorite for 7 minutes, followed by rinse with sterile water. Dechorionated embryo were transferred to axenic fly food supplemented with propionic acid (0.48ml/100ml) and Penicillin Streptomycin (Pen Strep) at 1ml/100ml concentration. The embryos were cultured at 25°C and validation of germ free state was done by homogenizing flies under aseptic condition and culturing the homogenate on Luria-Bertani medium plates. For axenic culture, all genotypes were grown together on axenic food and male progeny were collected at 3d-age to grow them to 30d-days for experiments.

QUANTIFICATION AND STATISTICAL ANALYSIS {#S22}
---------------------------------------

All data were analyzed with GraphPad Prism 7.0, except PC analysis and comparison of *Cdk5α null* and *Cdk5α-OE* expression profiles with other mutant conditions and qRT-PCR. These two analyses were done using R: The R Project for Statistical Computing, and qRT-PCR analyses using Microsoft Excel. Error bars (SEM or SD) were calculated using Prism 7.0 as specified in figure legends. The number of replicates and brain hemispheres used per experiments are provided in figure legends. t test was performed on 3 or 5 replicates, hence normality of data distribution was not calculated due to limited sample size, while ANOVA was used for most analyses, which is considered as robust against normality assumption. Statistical test used for each figure is provided in figure legend and detailed statistical data for all figures are compiled in [Table S2](#SD2){ref-type="supplementary-material"}.

DATA AND SOFTWARE AVAILABILITY {#S23}
------------------------------

Any data not included in [Table S2](#SD2){ref-type="supplementary-material"} are available on request from the lead contact (EG). All R code used for analysis of microarray data is available through <https://data.ninds.nih.gov>.
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![Both Gain and Loss of Cdk5α Induce the Degeneration of Dopaminergic Neurons\
Brains of 3-, 10-, 30-, and 45-day-old flies of the indicated genotypes were dissected and immunostained with anti-DTH antibody.\
(A) Representative projected confocal images of DA neurons labeled with anti-DTH antibody.\
(B) The number of DTH^+^ DA neurons per hemisphere is presented as mean ± SEM, along with individual counts. The pooled DA neuron count includes neurons from PPL1, PPL2, PPM1/2, PPM3, and PAL clusters. For individual counts in these clusters, see [Figure S1](#SD1){ref-type="supplementary-material"}. For each genotype and age, the number of hemispheres examined is presented at the bottom of the bar. Error bars indicate SEM. The significance of differences is relative to the age-matched control (one-way ANOVA with Dunnett's multiple correction). The DA neuron count in 45-day-old *Cdk5α-OE* shows an apparent rebound in numbers relative to 30 days; this reflects selective survival of only the fittest individuals at the oldest time point ([@R46]). For complete details of statistical analysis for this and all of the figures, see [Table S2](#SD2){ref-type="supplementary-material"}.\
(C) Top: projected confocal images of 30-day-old brains of DTH-stained control, *Cdk5α null*, and Rescue {*Cdk5α null; Tn\[Cdk5α\]*/+}. Bottom: counts showing mean ± SEM along with individual values. For the rescue samples, the significance of differences was calculated between rescue and age-matched *Cdk5α null* using one-way ANOVA with Tukey's multiple correction. In the rescue calculation, the same data for 30-day-old controls and *Cdk5α null* were used.](nihms-1517815-f0002){#F1}

![Altered Expression of Cdk5α Causes Overexpression of Anti-microbial Peptides\
(A) Principal-component analysis (PCA) of micro-array expression profiling data. Colored ovals represent individual samples (N = 5 biological replicates), color coded as indicated. PC2 is found to separate samples essentially by effective age; PC3 separates by the severity of the neurodegenerative phenotype.\
(B) *Z* scores of genes that make a statistically significant contribution to PC3. AMPs and other secreted innate immune proteins are represented by orange. Genes with predicted function as proteases and hydrolases are shown in blue.\
(C) qRT-PCR for the expression level of the AMPs listed (color key at top). RNA was isolated from the heads of flies of the indicated genotypes and ages. Fold change of AMP expression was determined relative to 3-day-old controls, with rp49 as an endogenous control, and is displayed as mean ± SEM for three biological replicates. Student's t test, as compared to 3-day-old control, was used to calculate significance ([Table S2](#SD2){ref-type="supplementary-material"}).\
(D) qRT-PCR for AMPs was performed and quantified as above, using RNA from the heads of 30-day-old flies that were *Cdk5α null*, without (−) or with (+) *Tn\[Cdk5α*^+^*\]* rescuing genomic transgenes. Statistical significance was assessed by t test for each AMP. Note that this transgene expresses at a lower level than the endogenous locus, so that the rescue of the phenotype is only expected to be partial ([@R46]). Student's t test, as compared to 30-day-old *Cdk5α null* was used to calculate significance. (Three biological replicates; error bars indicate SEM).](nihms-1517815-f0003){#F2}

![Cdk5α-Altered *Drosophila* Have Neuronal Expression of AMPs\
(A) Projected confocal image showing drosomycin expression (green) in the brains of 30-day-old *Cdk5α null Drosophila* along with embryonic lethal, abnormal vision (ELAV) (red, neuronal marker) and reversed polarity (Repo) (magenta, glial marker). Yellow arrowheads highlight drosomycin in glial cells, while white arrows highlight expression in neurons. Some GFP^+^ cells were observed that were positive for neither neuronal nor glial markers (stars); some of these resemble hemocytes. Five biological replicates were examined.\
(B) AMP expression in *Cdk5α null* flies with or without *Elav-GAL4*-mediated knock down of *Relish* expression. Fold change of AMPs was calculated versus 30-day-old controls and presented as mean ± SEM; significance in *Elav-GAL4; Cdk5α null* was assessed for each AMP by comparison to age-matched *Elav-Gal4*, while for *Elav-Gal4*;*Cdk5α null; Relish RI*, it was compared to *Elav-Gal4*;*Cdk5α null*, using Student's t test for five biological replicates.\
(C) DA neuron counts in 30-day-old *Elav-Gal4*, *Elav-Gal4*;*Cdk5α null*, and *Elav-Gal4*;*Cdk5α null;Relish RI*. Flies were aged at 25°C, and DA neurons were counted by staining with anti-TH antibody. Data are presented as mean ± SEM with individual counts shown. The number of brain hemispheres counted are at the bottom of each bar. Statistical significance was determined using one-way ANOVA with Tukey's multiple correction.](nihms-1517815-f0004){#F3}

![Overexpression of AMPs Induces Loss of DA Neurons\
(A) *TH-Gal4* was used to drive the indicated AMP genes in DA neurons, and the neuron number was counted at 3 and 30 days by immunostaining with anti-TH antibody. The graphs depict mean ± SEM for the four experimental conditions, and mean ± SD for the comparison of 3-day-old versus 30-day-old control; individual counts also are shown. The number of brain hemispheres counted is at the bottom of each bar. *UAS-Drosocin* and *UAS-Metchnikowin* flies show significant GAL4-independent expression and GAL4-independent loss of DA neurons at 30 days of age. For the expression level of these AMPs, see [Figure S3](#SD1){ref-type="supplementary-material"}. Significance analysis for *TH-Gal4* was done using an unpaired t test, while significance was measured by one-way ANOVA with Tukey's multiple correction for others.\
(B) qRT-PCR for the AMPs shown was performed on the RNA from the heads of 30-day-old flies of the indicated genotypes. Fold change of AMPs was calculated relative to 3-day-old controls. Statistical significance for *Cdk5α null* was assessed as compared to 30-day-old controls, while significance for *Cdk5α null;Rel*^*E20*^*/TM6B* was compared to the fold change in *Cdk5α null*. Statistical significance was assessed by Student's t test (three biological replicates; error bars indicate SEM).\
(C) Males of the indicated genotypes were aged at 25°C, and the brains were fixed, dissected, and examined for DA neuron number by immunostaining with anti-TH antibody at 30 days of age. Data are presented as mean ± SEMs, with individual values shown. The number of brain hemispheres examined is presented at the bottom of each bar. Statistical significance was determined using one-way ANOVA with Tukey's multiple correction.](nihms-1517815-f0005){#F4}

![Altered Cdk5α Levels Reduce Autophagy Efficiency\
(A and B) Flies of the indicated genotypes were aged to 30 days, and brains were fixed, dissected, and labeled with DAPI (blue), anti-TH (green), and anti-Ref(2)P (red).\
(A) Projected confocal images, including PPL1 cluster, showing separated channels and merged image, as well as a 3D surface rendering of a single TH^+^ cell (dotted yellow rectangle in merged image).\
(B) Ref(2)P^+^ puncta were counted using the ImageJ (NIH) particle counting tool, and data are presented as mean ± SEM, with individual values shown. Brain region including PPL1 cluster was examined for six hemispheres per genotype, and puncta were counted in two size ranges, 0.02--0.40 μm^2^ and \>0.40 μm^2^. Statistical significance was assessed by one-way ANOVA with Dunnett's multiple correction. For a 3D view documenting the localization of Ref(2)P puncta inside the DA neuron, the 3D cropping tool of Imaris (Bitplane) was used, followed by surface rendering and manual pruning of puncta outside the DA neuron.\
(C) *TH-Gal4* was used to drive *UAS-GFP-mCherry-Atg8a* in DA neurons. Brains were dissected without fixation, and fluorescence was examined. DA neurons of control flies (*w*^+^*;UAS-GFP-mCherry-Atg8a/CyO;TH-Gal4/TM6B*) have mostly mCherry^+^ puncta, while *Cdk5α null* flies (w^+^; *Cdk5α/DfC2,UAS-GFP-mCherry-Atg8a;TH-Gal4/TM6B)* have mostly double-positive puncta (yellow). Six biological replicates were used for this experiment.\
(D) Western immunoblot with anti-GFP antibody was used to quantify Vha13 protein in the extract of 30-day-old heads of flies of the indicated genotypes bearing a Vha-13-GFP gene trap. Left: typical immunoblot; numbers give the molecular weights of the markers. Right: quantification, displaying mean ± SEM (average of three biological replicates, normalized with anti-tubulin as loading control). Significance determined by paired t test.\
(E) qRT-PCR was performed in biological triplicate, as above, to quantify Mitf expression in the RNA of the heads of the indicated genotypes. Error bars indicate SEM. UAS-Mitf was driven with a third chromosome insert of *ELAV-GAL4* that has very low adult expression (BL8760).\
(F) Western immunoblot (left) and quantification (right) of cysteine protease (Cp1), detected with anti-Cp1 antibody in the extract of the heads of the indicated genotypes isolated at 30 days of age. The Cp1 value presented is an average of three biological replicates, normalized with anti-tubulin as the loading control. Error bars indicate SEM. Raw intensity values from all of the trials are given in Table S4. Significance was assessed by one-way ANOVA with Dunnett's multiple correction. The molecular weights of the markers are indicated next to the blots.](nihms-1517815-f0006){#F5}

![Reduced Autophagy Induces AMP Expression and DA Neuron Loss in Aged Flies\
(A) Ref(2)P accumulation in the brains of *Atg8a*^*1*^*/Y* flies. Flies were aged to 30 days; brains were fixed, dissected, and stained with DAPI (blue), anti-TH (green), and anti-Ref(2)P (red). Separated channels and merged image are shown as projected confocal images; the rightmost panel is a 3D rendering of a single TH^+^ cell showing Ref(2)P accumulation inside the cell (cell highlighted with yellow box in the merged image). Five biological replicates were examined for Ref(2)P accumulation.\
(B) AMP expression in the heads of *Atg8a*^*1*^*/Y* flies. RNA was isolated from the heads of 30-day-old flies that were *Atg8a*^*1*^*/Y* or controls, and qRT-PCR was performed, as above. Bars show fold change of the expression level in mutants relative to age-matched controls (mean ± SEM; significance was calculated using Student's t test; five biological replicates).\
(C) DA neuron counts in the brains of *Atg8a*^*1*^*/Y* flies and controls. Flies were aged to 30 days, and the brains were fixed, dissected, and assayed for DA neuron number by fluorescence microscopy after immunostaining with anti-TH. Bars indicate mean ± SEM with individual values shown. The number of brain hemispheres examined is at the bottom of each bar, and significance was assessed relative to controls (t test).\
(D) Ref(2)P accumulation in the brains of controls and 30-day-old *Cdk5α null* without and with low-level, GAL4-driven expression of Mitf. Top: projections of the brains of the indicated genotypes, which were fixed, dissected, and immunostained with anti-Ref(2)P. Bottom: quantification of Ref(2)P puncta from six to eight brain hemispheres of each condition. Data are presented as mean ± SEM, along with individual counts. Two-way ANOVA with Tukey's multiple correction was used for statistical analysis. *ELAV-Gal4* \> *UAS-Mitf* expression generated general cytoplasmic background label with this antibody; background subtraction was performed by rolling circle (5.0 pixels) before counting the puncta. For an unprocessed image, see [Figure S6](#SD1){ref-type="supplementary-material"}.\
(E) AMP expression levels in *Cdk5α null* flies without and with ELAV-driven restoration of Mitf. qRT-PCR for the AMP level was performed on the RNA from the heads of 30-day-old flies, as previously described. Fold change of AMPs was calculated versus 30-day-old controls and presented as mean ± SEM; significance was assessed for each AMP by comparison to age-matched *Cdk5α null* using three biological replicates and Student's t test.\
(F) DA neuron counts in 30-day-old *Cdk5α null* and *Cdk5α null; ELAV-Gal4/UAS-Mitf*. Flies were aged at 25°C, and DA neurons were counted, as before, by staining with anti-TH antibody. Data are presented as mean ± SD, with individual counts shown. The number of brain hemispheres counted are at the bottom of each bar, and significance is by comparison to *Cdk5α null* (Student's t test).](nihms-1517815-f0007){#F6}

###### 

KEY RESOURCES TABLE

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  REAGENT or RESOURCE                                                                                         SOURCE                                       IDENTIFIER
  ----------------------------------------------------------------------------------------------------------- -------------------------------------------- ---------------------------------------------------------------------------------------------------
  Antibodies                                                                                                                                               

  Anti-DTH (rabbit)                                                                                           Laboratory of W. Neckameyer ([@R32])         N/A

  Anti-Ref(2)P (rabbit)                                                                                       Laboratory of I. Nezis ([@R33])              N/A

  Anti-TH (mouse) clone LNC1                                                                                  Milipore                                     Cat\#:MAB318, RRID:AB_2201528

  Anti-Cathepsin L(rabbit) Cp1                                                                                abcam                                        Cat\#:Ab58991, RRID:AB_940826

  Anti-green fluorescent protein, rabbit IgG                                                                  Invitrogen                                   Cat\#:A11122, RRID:AB_221569

  Beta tubulin                                                                                                Developmental studies hybridoma bank         Cat\#:E7, RRID:AB_528499

  Anti-Repo (Mouse)                                                                                           Developmental studies hybridoma bank         Cat\#:8D12, RRID:AB_528448

  Anti-ELAV (Rat)                                                                                             Developmental studies hybridoma bank         Cat\#:7E8A10, RRID:AB_528218

  Alexa Fluor®568 Goat anti-mouse IgG                                                                         Life technologies                            Cat\#:A11031, RRID:AB_144696

  Alexa Fluor®488 Goat anti-mouse IgG                                                                         Life technologies                            Cat\#:A11029, RRID:AB_2534088

  Alexa Fluor®568 Goat anti-rabbit IgG                                                                        Life technologies                            Cat\#:A11036, RRID:AB_10563566

  Alexa Fluor™633 Goat anti-mouse IgG                                                                         Invitrogen                                   Cat\#:A21126, RRID:AB_2535768

  Alexa Fluor®568 Goat anti-rat IgG (H+L)                                                                     Molecular Probes                             Cat\#:A11077, RRID:AB_141874

  IRDye700DX®Goat Anti-rabbit IgG                                                                             Rockland INC                                 Cat\#:611-130-122, RRID:AB_220148

  IRDye800DX®Goat Anti-mouse IgG                                                                              Rockland INC                                 Cat\#:610-132-121, RRID:AB_220125

  IRDye700DX®Goat Anti-mouse IgG                                                                              Rockland INC                                 Cat\#:610-130-121, RRID:AB_220121

  IRDye®800Goat Anti-rabbit IgG                                                                               Rockland INC                                 Cat\#:611-132-002, RRID:AB_1660971

  VECTASHIELD Antifade Mounting Medium                                                                        Vector Laboratories, Burlingame, CA          Cat\#: H-1000, RRID:AB_2336789

  VECTASHIELD Antifade Mounting Medium with DAPI                                                              Vector Laboratories, Burlingame, CA          Cat\#: H-1200, RRID:AB_2336790

  Chemicals, Reagents and Kit                                                                                                                              

  PowerUp SYBR Green Master Mix                                                                               Applied biosystems                           Cat\#:A25742, N/A

  High capacity cDNA Reverse Transcription Kit                                                                Applied biosystems                           Cat\#:4368814, N/A

  TRIzol® reagent                                                                                             Life technologies                            Cat\#:15596026, N/A

  Paraformaldehyde 16% Solution, EM Grade                                                                     Electron Microscopy Sciences                 Cat\#: 15710, N/A

  Schneider's Drosophila Medium                                                                               Life technologies                            Cat\#:21720-024, N/A

  Halt Protease Inhibitor Cocktail                                                                            ThermoFisher Scientific                      Cat\#:87785, N/A

  iBlot®2NC Regular Stacks                                                                                    Invitrogen/ThermoFisher Scientific           Cat\#:IB23001, N/A

  Bolt 4--12% Bis-Tris Plus gel                                                                               Invtrogen/ThermoFisher Scientific            Cat\#:NW04120BOX, N/A

  Nutri-Fly® BF, 10 × 1L Packets                                                                              Genesee Scientific                           Cat\#: 66-112, N/A

  GIBCO Penicillin-Streptomycin (10,000 U/mL)                                                                 Life technologies                            Cat\#: 15140-122, N/A

  Fly media, CT modified + green dye                                                                          K.D Medicals                                 Cat\#: IMT-0756, N/A

  Oligonucleotides                                                                                                                                         

  [Table S5](#SD1){ref-type="supplementary-material"}                                                                                                      N/A

  Experimental Models: Organism/Strains                                                                                                                    

  *D. melanogaster: w\[\*\]; P{w\[+mC\] = ple-GAL4.F}3*                                                       Bloomington Drosophila Stock Center          BDSC:8848, FlyBase: FBst0008848

  *D. melanogaster: w\[1118\]; Rel\[E20\] e\[s\]*                                                             Bloomington Drosophila Stock Center          BDSC:9457, FlyBase: FBst0009457

  *D. melanogaster: y\[1\] w\[1118\]; P{w\[+mC\] = UASp-GFP-mCherry-Atg8a}2*                                  Bloomington Drosophila Stock Center          BDSC:37749, FlyBase: FBst0037749

  *D. melanogaster: w\[1118\] P{w\[+mC\] = EP}Atg8a\[EP362\]*                                                 Laboratory of K. D. Finley ([@R45])          BDSC:10107, FlyBase: FBst0010107

  *D. melanogaster: w\*; P{UAS-mCherry.NLS}3*                                                                 Bloomington Drosophila Stock Center          BDSC:38424, FlyBase: FBst0038424

  *D. melanogaster: y\[1\] v\[1\]; P{y\[+t7.7\]v \[+t1.8\] = TRiP.HM05154}attP2*                              Bloomington Drosophila Stock Center          BDSC:28943, FlyBase: FBst0028943

  *D. melanogaster: pStinger-Vha13--3*                                                                        Laboratory of F. Pignoni ([@R57])            N/A

  *D. melanogaster: pUASTattB-Mitf (96E) / SM6::TM6B*                                                         Laboratory of F. Pignoni ([@R57])            N/A

  *D. melanogaster:UAS-Attacin C*                                                                             Laboratory of B. Ganetzky ([@R3])            N/A

  *D. melanogaster:UAS-Droscin/CyO*                                                                           Laboratory of B. Ganetzky ([@R3])            N/A

  *D. melanogaster:UAS-Drosomycin*                                                                            Laboratory of B. Ganetzky ([@R3])            N/A

  *D. melanogaster:UAS-Mtchnikowin/TM3Sb*                                                                     Laboratory of B. Ganetzky ([@R3])            N/A

  *D. melanogaster:Oregon R*^+^ *(w*^+^*)*                                                                    Laboratory of E. Giniger ([@R7]; [@R46])     N/A

  *D. melanogaster:w*^+^; *Cdk5α-null*                                                                        Laboratory of E. Giniger ([@R7]; [@R46])     N/A

  *D. melanogaster: w+; P\[w+,TnCdk5α\]R244/P\[w+,TnCdk5α\]R244; P\[w+,Tn Cdk5α\] R157/P\[w+,TnCdk5α\]R157*   Laboratory of E. Giniger ([@R7]; [@R46])     N/A

  *D. melanogaster: Df(Cdk5α)*^*C2*^                                                                          Laboratory of E. Giniger ([@R7]; [@R46])     N/A

  *D. melanogaster: w+; Cdk5α / Cdk5α; P\[w+,Tn Cdk5α\] R157/+*                                               Laboratory of E. Giniger ([@R7]; [@R46])     N/A

  *D. melanogaster: ELAV Gal4 (on X chromosome)*                                                              Laboratory of E. Giniger ([@R7]; [@R46])     N/A

  *D. melanogaster: w\[\*\]; P{w\[+mC\] = GAL4-elav.L}3*                                                      Bloomington Drosophila Stock Center          BDSC:8760, FlyBase: FBst0008760

  *D. melanogaster: Drs-GFP*                                                                                  Laboratory of Jean-Marc Reichhart ([@R10])   N/A

  Software                                                                                                                                                 

  Fiji                                                                                                                                                     <https://fiji.sc/>; RRID:SCR_002285

  Zeiss LSM                                                                                                   Carl Zeiss Microscopy                        <https://www.zeiss.com/microscopy/int/products/confocal-microscopes/lsm-800-with-airyscan.html>;\
                                                                                                                                                           RID:SCR_015963

  Imaris version 8.2.1                                                                                        Bitplane                                     <http://www.bitplane.com/imaris/imaris>;\
                                                                                                                                                           RID:SCR_007370

  Prism 7                                                                                                     GraphPad                                     <https://www.graphpad.com>;\
                                                                                                                                                           RRID:SCR_002798

  AutoQuant X                                                                                                 Media Cybernetics                            <http://www.mediacy.com/autoquantx3>;\
                                                                                                                                                           RRID:SCR_002465
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### Highlights

-   Altering Cdk5 activity causes degeneration of dopamine neurons in *Drosophila*

-   Increasing or decreasing Cdk5 activity impairs autophagic flux

-   Impairing autophagic flux hyperactivates innate immunity

-   The hyperactivity of immunity, in turn, causes the age-dependent neuron loss
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